» Articles » PMID: 20956321

LKB1 Inhibits Lung Cancer Progression Through Lysyl Oxidase and Extracellular Matrix Remodeling

Overview
Specialty Science
Date 2010 Oct 20
PMID 20956321
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

LKB1 loss-of-function mutations, observed in ∼30% of human lung adenocarcinomas, contribute significantly to lung cancer malignancy progression. We show that lysyl oxidase (LOX), negatively regulated by LKB1 through mTOR-HIF-1α signaling axis, mediates lung cancer progression. Inhibition of LOX activity dramatically alleviates lung cancer malignancy progression. Up-regulated LOX expression triggers excess collagen deposition in Lkb1-deficient lung tumors, and thereafter results in enhanced cancer cell proliferation and invasiveness through activation of β1 integrin signaling. High LOX level and activity correlate with poor prognosis and metastasis. Our findings provide evidence of how LKB1 loss of function promotes lung cancer malignancy through remodeling of extracellular matrix microenvironment, and identify LOX as a potential target for disease treatment in lung cancer patients.

Citing Articles

Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancer.

Shu C, Li J, Rui J, Fan D, Niu Q, Bai R Nat Commun. 2025; 16(1):2324.

PMID: 40057483 PMC: 11890758. DOI: 10.1038/s41467-025-57297-5.


The Effect of Fuzheng Yiai Decoction on the Transdifferentiation of Lung Adenocarcinoma in EGFR-TKI-Resistant Mice.

Sun J, Luo D, Li H, Zhang D, Liu Y, Jin S Can Respir J. 2024; 2024:8827810.

PMID: 39735556 PMC: 11671638. DOI: 10.1155/carj/8827810.


Pulmonary lysyl oxidase expression and its role in seeding Lewis lung carcinoma cells.

Jasmer K, Shanbhag V, Munoz Forti K, Woods L, Gudekar N, Weisman G Clin Exp Metastasis. 2024; 42(1):7.

PMID: 39714512 DOI: 10.1007/s10585-024-10325-y.


Forcing the code: tension modulates signaling to drive morphogenesis and malignancy.

Narain R, Muncie-Vasic J, Weaver V Genes Dev. 2024; 39(1-2):163-181.

PMID: 39638568 PMC: 11789492. DOI: 10.1101/gad.352110.124.


FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma.

Kanzaki R, Reid S, Bolivar P, Sjolund J, Staaf J, Larsson S Int J Cancer. 2024; 156(2):431-446.

PMID: 39244734 PMC: 11578086. DOI: 10.1002/ijc.35174.


References
1.
Keith B, Simon M . Hypoxia-inducible factors, stem cells, and cancer. Cell. 2007; 129(3):465-72. PMC: 3150586. DOI: 10.1016/j.cell.2007.04.019. View

2.
Gandhi L, McNamara K, Li D, Borgman C, McDermott U, Brandstetter K . Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis. Cancer Prev Res (Phila). 2009; 2(4):330-7. PMC: 2696128. DOI: 10.1158/1940-6207.CAPR-08-0213. View

3.
Bild A, Yao G, Chang J, Wang Q, Potti A, Chasse D . Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2005; 439(7074):353-7. DOI: 10.1038/nature04296. View

4.
Tomlinson I, Houlston R . Peutz-Jeghers syndrome. J Med Genet. 1998; 34(12):1007-11. PMC: 1051153. DOI: 10.1136/jmg.34.12.1007. View

5.
Ji H, Ramsey M, Hayes D, Fan C, McNamara K, Kozlowski P . LKB1 modulates lung cancer differentiation and metastasis. Nature. 2007; 448(7155):807-10. DOI: 10.1038/nature06030. View